STERIS Market Capitalization from 2010 to 2024
| STE Stock | USD 219.06 1.59 0.73% |
Check STERIS Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STERIS Plc's main balance sheet or income statement drivers, such as Depreciation And Amortization of 593.5 M, Total Revenue of 5.4 B or Gross Profit of 2.3 B, as well as many indicators such as Price To Sales Ratio of 3.05, Dividend Yield of 0.0165 or PTB Ratio of 4.48. STERIS financial statements analysis is a perfect complement when working with STERIS Plc Valuation or Volatility modules.
STERIS | Market Capitalization |
Latest STERIS Plc's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of STERIS plc over the last few years. It is STERIS Plc's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STERIS Plc's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 21.62 B | 10 Years Trend |
|
Market Cap |
| Timeline |
STERIS Market Capitalization Regression Statistics
| Arithmetic Mean | 5,481,640,188 | |
| Geometric Mean | 4,104,165,156 | |
| Coefficient Of Variation | 27.70 | |
| Mean Deviation | 745,673,945 | |
| Median | 5,936,954,580 | |
| Standard Deviation | 1,518,257,395 | |
| Sample Variance | 2305105.5T | |
| Range | 5.9B | |
| R-Value | 0.37 | |
| Mean Square Error | 2135837.6T | |
| R-Squared | 0.14 | |
| Significance | 0.17 | |
| Slope | 126,851,840 | |
| Total Sum of Squares | 32271477.2T |
STERIS Market Capitalization History
About STERIS Plc Financial Statements
STERIS Plc stakeholders use historical fundamental indicators, such as STERIS Plc's Market Capitalization, to determine how well the company is positioned to perform in the future. Although STERIS Plc investors may analyze each financial statement separately, they are all interrelated. For example, changes in STERIS Plc's assets and liabilities are reflected in the revenues and expenses on STERIS Plc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in STERIS plc. Please read more on our technical analysis and fundamental analysis pages.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company was founded in 1985 and is based in Dublin, Ireland. Steris Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 16000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:Check out the analysis of STERIS Plc Correlation against competitors. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.305 | Dividend Share 2.13 | Earnings Share 5.96 | Revenue Per Share 53.903 | Quarterly Revenue Growth 0.073 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.